# Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction

arXiv: https://arxiv.org/abs/2208.11267 · HTML: https://mlsanity.com/paper/2208.11267/

## Key facts

- Cited by 4 papers in the map (data through 14 Oct 2026).
- Builds on 6 of its 20 references that are in the map.
- First posted on arXiv 24 Aug 2022.

## Builds on (most cited first, 6 of 6)

- [Semi-Supervised Classification with Graph Convolutional Networks](https://mlsanity.com/paper/1609.02907/) (2016)
- [Graph Attention Networks](https://mlsanity.com/paper/1710.10903/) (2017)
- [How Powerful are Graph Neural Networks?](https://mlsanity.com/paper/1810.00826/) (2018)
- [Neural Message Passing for Quantum Chemistry](https://mlsanity.com/paper/1704.01212/) (2017)
- [Drug-Drug Adverse Effect Prediction with Graph Co-Attention](https://mlsanity.com/paper/1905.00534/) (2019)
- [Drug Similarity Integration Through Attentive Multi-view Graph Auto-Encoders](https://mlsanity.com/paper/1804.10850/) (2018)

## Built on by (most cited first, 4 of 4)

- [Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction](https://mlsanity.com/paper/2306.05257/) (2023)
- [ZeroDDI: A Zero-Shot Drug-Drug Interaction Event Prediction Method with Semantic Enhanced Learning and Dual-Modal Uniform Alignment](https://mlsanity.com/paper/2407.00891/) (2024)
- [CADGL: Context-Aware Deep Graph Learning for Predicting Drug-Drug Interactions](https://mlsanity.com/paper/2403.17210/) (2024)
- [CrossADR: enhancing adverse drug reactions prediction for combination pharmacotherapy with cross-layer feature integration and cross-level associative learning](https://mlsanity.com/paper/2603.15047/) (2026)

## Abstract (arXiv)

Concomitant administration of drugs can cause drug-drug interactions (DDIs). Some drug combinations are beneficial, but other ones may cause negative effects which are previously unrecorded. Previous works on DDI prediction usually rely on hand-engineered domain knowledge, which is laborious to obtain. In this work, we propose a novel model, Molecular Substructure-Aware Network (MSAN), to effectively predict potential DDIs from molecular structures of drug pairs. We adopt a Transformer-like substructure extraction module to acquire a fixed number of representative vectors that are associated with various substructure patterns of the drug molecule. Then, interaction strength between the two drugs' substructures will be captured by a similarity-based interaction module. We also perform a substructure dropping augmentation before graph encoding to alleviate overfitting. Experimental results from a real-world dataset reveal that our proposed model achieves the state-of-the-art performance. We also show that the predictions of our model are highly interpretable through a case study.
